New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions

JAMA Medical News: Discussing timely topics in clinical medicine, biomedical sciences, public health, and health policy by American Medical Association

Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semaglutide-amylin analogue i...View more